Literature DB >> 3498581

Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.

T Uchiyama1, Y Kamagata, X J Yan, M Kohno, M Yoshioka, H Fujikawa, H Igarashi, M Okubo, F Awano, T Saito-Taki.   

Abstract

Toxic shock syndrome toxin-1 (TSST-1) is an exotoxin produced by Staphylococcus aureus isolated from patients with toxic shock syndrome. We investigated the proliferative response of human lymphocytes and their interleukin 2 (IL-2) production after stimulation with TSST-1 in vitro. Human cord blood mononuclear cells (HCBM) and human peripheral blood mononuclear cells (HPBM) could proliferate with TSST-1 stimulation. T cell-depleted HPBM showed only a marginal response to this toxin. A IL-2-like factor with a molecular weight of 15-18 kD was obtained from the supernatants of TSST-1-stimulated HPBM cultures. The factor was absorbed by CTLL-2 cells but not by T cell-depleted murine spleen cells, indicating that it is IL-2. HPBM are very sensitive to TSST-1: a low concentration of TSST-1 (0.01 ng/ml in 36 h stimulation) and a short period of stimulation (8 h at 10 ng/ml of the toxin) were fully effective for HPBM to produce substantial amounts of IL-2. Removal of T cells abrogated the TSST-1-induced IL-2 production by HPBM. Reconstituted cell cultures of nylon wool column-passed T cells and macrophages produced IL-2 by TSST-1 stimulation and, furthermore, the accessory activity of the macrophages could be partially replaced by a macrophage-derived factor containing interleukin 1. These findings indicate that T cells require macrophages or IL-1 for TSST-1-induced production of IL-2. The roles of lymphokines, including IL-2, in the development of this illness are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498581      PMCID: PMC1542756     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Purification and some physicochemical properties of toxic-shock toxin.

Authors:  R F Reiser; R N Robbins; G P Khoe; M S Bergdoll
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

4.  Mechanism of lipopolysaccharide-induced immunosuppression: immunological activity of B cell subsets responding to T-dependent or T-independent antigens in lipopolysaccharide-preinjected mice.

Authors:  T Uchiyama; Y Kamagata; M Yoshioka
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

5.  Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.

Authors:  N J Poindexter; P M Schlievert
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

6.  Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.

Authors:  J K Rasheed; R J Arko; J C Feeley; F W Chandler; C Thornsberry; R J Gibson; M L Cohen; C D Jeffries; C V Broome
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

7.  Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.

Authors:  V V Micusan; G Mercier; A R Bhatti; R F Reiser; M S Bergdoll; D Oth
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

8.  Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro.

Authors:  S E Calvano; F W Quimby; A C Antonacci; R F Reiser; M S Bergdoll; P Dineen
Journal:  Clin Immunol Immunopathol       Date:  1984-10

9.  In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

Authors:  M T Lotze; Y L Matory; S E Ettinghausen; A A Rayner; S O Sharrow; C A Seipp; M C Custer; S A Rosenberg
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins.

Authors:  H Igarashi; H Fujikawa; H Usami; S Kawabata; T Morita
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

View more
  17 in total

1.  Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.

Authors:  T Uchiyama; S Saito; H Inoko; X J Yan; K Imanishi; M Araake; H Igarashi
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Characterization of novel staphylococcal enterotoxin-like toxin type P.

Authors:  Katsuhiko Omoe; Ken'ichi Imanishi; Dong-Liang Hu; Hidehito Kato; Yoshitaku Fugane; Yohei Abe; Shoji Hamaoka; Yutaka Watanabe; Akio Nakane; Takehiko Uchiyama; Kunihiro Shinagawa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Elevated levels of interleukin 6 in serum of patients with serious group A streptococcal infections.

Authors:  A Norrby; M Norgren; S E Holm
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

4.  Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen.

Authors:  N Takahashi; H Kato; K Imanishi; K Miwa; S Yamanami; H Nishida; T Uchiyama
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.

Authors:  T Uchiyama; Y Kamagata; X J Yan; A Kawachi; H Fujikawa; H Igarashi; M Okubo
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 6.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

7.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards.

Authors:  Ken Kikuchi; Naoto Takahashi; Chuncheng Piao; Kyoichi Totsuka; Hiroshi Nishida; Takehiko Uchiyama
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Cloning, expression, and characterization of the superantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae.

Authors:  Jizi Zhao; Tomohito Hayashi; Susanna Saarinen; Anastassios C Papageorgiou; Hidehito Kato; Ken'ichi Imanishi; Teruo Kirikae; Ryo Abe; Takehiko Uchiyama; Tohru Miyoshi-Akiyama
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

10.  Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells.

Authors:  T Miyoshi-Akiyama; K Imanishi; T Uchiyama
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.